Collectively, these results illustrated a critical role of PTTG1 in MDA-MB-231 breast cell invasion and suggested that inhibition of PTTG1 expression is contributed, at least in part, to the inhibition of breast cancer invasion by simvastatin treatment. This evidence concerns the gene PTTG1 and breast carcinoma.